Pulmonary Rehabilitation and Functional Independence: Impact on Survival in Patients with Fibrotic Interstitial Lung Disease or Chronic Obstructive Pulmonary Disease

COPDEmphysema

Dupilumab reduces exacerbations and improves lung function in patients with chronic obstructive pulmonary disease and emphysema: Phase 3 randomized trial (BOREAS)

Respir Med

Bhatt SP, Rabe KF, Hanania NA, Vogelmeier CF, Bafadhel M, Christenson SA, Papi A, Singh D, Laws E, Dakin P, Maloney J, Lu X, Bauer D, Bansal A, Robinson LB, Abdulai RM

doi: 10.1016/j.rmed.2024.107846

RECOMMENDED

AsthmaCOPDInterstitial Lung Disease

Incidence and prevalence of asthma, chronic obstructive pulmonary disease and interstitial lung disease between 2004 and 2023: harmonised analyses of longitudinal cohorts across England, Wales, South-East Scotland and Northern Ireland

★ 2 Recommended by Dr Martin Frey, Faculty Member

Thorax

Whittaker H, Kramer Fiala Machado A, Hatam S, Cook S, Scully S, Evans HTT, Bolton T, Kallis C, Busby J, Heaney LG, Sheikh A, Quint JK, CVD-COVID-UK/COVID-IMPACT Consortium

doi: 10.1136/thorax-2024-222699

Further Publications

Functional status following pulmonary rehabilitation in people with interstitial lung disease: A systematic review and meta-analysis

Chron Respir Dis

Rodrigues G, Santos R, Pinto R, Oliveira A, Marques A

doi: 10.1177/14799731241255138

COPD

A Comparison of GOLD and STAR Severity Stages in Individuals with Chronic Obstructive Pulmonary Disease Undergoing Pulmonary Rehabilitation

Chest

Ambrosino P, Vitacca M, Marcuccio G, Spanevello A, Ambrosino N, Maniscalco M

doi: 10.1016/j.chest.2024.10.013

RECOMMENDED

Interstitial Lung DiseasePneumonia

Clinical Profiles, Survival, and Lung Function Outcomes in ANCA-Associated Interstitial Lung Disease: An Observational Study

★ 3 Recommended by Dr Martin Frey, Faculty Member

★ 1 Recommended by Dr Marcus Hesse, Faculty Member

J Clin Med

Valero-Martínez C, Valenzuela C, Baldivieso Achá JP, Martínez-Besteiro E, Quiroga-Colina P, Alfranca A, Vicente-Rabaneda EF, Muñiz SH, Castañeda S, García-Vicuña R

doi: 10.3390/jcm14010229

RECOMMENDED

Interstitial Lung Disease

Characteristics of Pulmonary Rehabilitation Programs and their Effects on Exercise Capacity and Health Related Quality of Life (HRQoL) in Patients with Interstitial Lung Disease: A Systematic Review and Meta-Analysis

★ 2 Recommended by Dr Martin Frey, Faculty Member

★ 2 Recommended by Dr Marcus Hesse, Faculty Member

Respir Med

Salazar JJ, Mirza FT, Uzzaman MN, Shunmugam RH, Shazana NZ, Pinnock H, Hirani N, Rabinovich RA

doi: 10.1016/j.rmed.2024.107936

RECOMMENDED

Interstitial Lung Disease

Implications of the 2022 lung function update and GLI global reference equations among patients with interstitial lung disease

★ 2 Recommended by Dr Martin Frey, Faculty Member

★ 1 Recommended by Dr Marcus Hesse, Faculty Member

Thorax

Li A, Teoh A, Troy L, Glaspole I, Wilsher ML, de Boer S, Wrobel J, Moodley YP, Thien F, Gallagher H, Galbraith M, Chambers DC, Mackintosh J, Goh N, Khor YH, Edwards A, Royals K, Grainge C, Kwan B, Keir GJ, Ong C, Reynolds PN, Veitch E, Chai GT, Ng Z, Tan GP, Jackson D, Corte T, Jo H

doi: 10.1136/thorax-2024-221813

RECOMMENDED

Pulmonary Hypertension

Impact of Preoperative Body Mass Index on Long-term Survival, Quality of Life, and Functional Outcomes after Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension: Results from the UK National Cohort

★ 2 Recommended by Dr Martin Frey, Faculty Member

★ 1 Recommended by Dr Marcus Hesse, Faculty Member

J Heart Lung Transplant

Chiu S, Bunclark K, Appenzeller P, Ghani H, Taboada D, Sheares K, Toshner M, Pepke-Zaba J, Cannon J, Taghavi F, Tsui S, Ng C, Jenkins DP

doi: 10.1016/j.healun.2024.09.005

RECOMMENDED

COPD

A Research Agenda to Improve Outcomes in Patients with Chronic Obstructive Pulmonary Disease and Cardiovascular Disease. An Official American Thoracic Society Research Statement

★ 2 Recommended by Dr Martin Frey, Faculty Member

★ 2 Recommended by Dr Marcus Hesse, Faculty Member

Am J Respir Crit Care Med

Myers LC, Quint JK, Hawkins NM, Putcha N, Hamilton A, Lindenauer P, Wells JM, Witt LJ, Shah SP, Lee T, Nguyen H, Gainer C, Walkey A, Mannino DM, Bhatt SP, Barr RG, Mularski R, Dransfield M, Khan SS, Gershon AS, Divo M, Press VG

doi: 10.1164/rccm.202407-1320ST

Related content

Dupilumab reduces exacerbations and improves lung function in patients with chronic obstructive pulmonary disease and emphysema: Phase 3 randomized trial (BOREAS)

Incidence and prevalence of asthma, chronic obstructive pulmonary disease and interstitial lung disease between 2004 and 2023: harmonised analyses of longitudinal cohorts across England, Wales, South-East Scotland and Northern Ireland

Functional status following pulmonary rehabilitation in people with interstitial lung disease: A systematic review and meta-analysis

A Comparison of GOLD and STAR Severity Stages in Individuals with Chronic Obstructive Pulmonary Disease Undergoing Pulmonary Rehabilitation

Clinical Profiles, Survival, and Lung Function Outcomes in ANCA-Associated Interstitial Lung Disease: An Observational Study

Characteristics of Pulmonary Rehabilitation Programs and their Effects on Exercise Capacity and Health Related Quality of Life (HRQoL) in Patients with Interstitial Lung Disease: A Systematic Review and Meta-Analysis

Implications of the 2022 lung function update and GLI global reference equations among patients with interstitial lung disease

Impact of Preoperative Body Mass Index on Long-term Survival, Quality of Life, and Functional Outcomes after Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension: Results from the UK National Cohort

A Research Agenda to Improve Outcomes in Patients with Chronic Obstructive Pulmonary Disease and Cardiovascular Disease. An Official American Thoracic Society Research Statement